Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Aspira Women's Health Inc. (AWHL : OTC)

• Company Description    Aspira Women's Health Inc. engaged in the discovery, development and commercialization of testing options and bio-analytical solutions for women's health. Aspira Women's Health Inc., formerly known as Vermillion Inc., is based in AUSTIN, Texas. Number of Employees: 66

• Price / Volume Information    Yesterday's Closing Price: $0.63 Daily Weekly Monthly 20 Day Moving Average: 91,217 shares Shares Outstanding: 42.66 (millions) Market Capitalization: $26.87 (millions) Beta: 1.72 52 Week High: $0.79 52 Week Low: $0.02 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 53.85% 54.11% 12 Week 0.03% -1.58% Year To Date 0.00% 0.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 - AUSTIN,TX 78738 USA ph: 512-519-0400 fax: 512-439-6908 investors@aspirawh.com http://www.aspirawh.com

• General Corporate Information    Officers Michael Buhle - Chief Executive Officer and President Jannie Herchuk - Chair of the Board of Directors James Crawford - Vice President of Finance Ellen Beausang - Director Stefanie Cavanaugh - Director Peer Information Aspira Women's Health Inc. (ABMD) Aspira Women's Health Inc. (DMDS) Aspira Women's Health Inc. (CPWY.) Aspira Women's Health Inc. (EQUR) Aspira Women's Health Inc. (ECIA) Aspira Women's Health Inc. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 04537Y208 SIC: 2835 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 03/26/26 Share - Related Items Shares Outstanding: 42.66 Most Recent Split Date: 5.00 (0.07:1) Beta: 1.72 Market Capitalization: $26.87 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 03/26/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: 2.88 EPS Growth vs. Year Ago Period: 43.48% vs. Previous Quarter: -85.71% Sales Growth vs. Year Ago Period: 2.13% vs. Previous Quarter: -4.12% ROE 12/31/25 - - 09/30/25 - - 06/30/25 - - ROA 12/31/25 - - 09/30/25 - -176.76 06/30/25 - -172.68 Current Ratio 12/31/25 - - 09/30/25 - 1.39 06/30/25 - 0.90 Quick Ratio 12/31/25 - - 09/30/25 - 1.32 06/30/25 - 0.83 Operating Margin 12/31/25 - - 09/30/25 - -115.66 06/30/25 - -101.78 Net Margin 12/31/25 - - 09/30/25 - -115.66 06/30/25 - -101.78 Pre-Tax Margin 12/31/25 - - 09/30/25 - -115.66 06/30/25 - -101.78 Book Value 12/31/25 - - 09/30/25 - -0.10 06/30/25 - -0.08 Inventory Turnover 12/31/25 - - 09/30/25 - 11.82 06/30/25 - 11.67 Debt-to-Equity 12/31/25 - - 09/30/25 - - 06/30/25 - - Debt-to-Capital 12/31/25 - - 09/30/25 - - 06/30/25 - -

Powered by Zacks Investment Research ©